- Supported exchanges /
- F /
- 40M.F
NANEXA AB (40M F) stock market data APIs
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
NANEXA AB Financial Data Overview
0.096 | |
0.1015 | |
- | |
0.1015 | |
0.096 | |
0.0278-0.148 | |
17 906 K | |
136 M | |
53 393 K | |
1.766 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NANEXA AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 53 393 K
- EBITDA -63 564 000
- Earnings Per Share -0.07
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NANEXA AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get NANEXA AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: